The company reported its 2025 financial results, including a $144 million impairment charge in its orthodontic segment and a plan to generate $120 million in annualized cost savings.

Dentsply Sirona announced its financial results for the fourth quarter and full year of 2025, along with a new restructuring plan and the elimination of its quarterly cash dividend. The company also reported a $144 million non-cash impairment charge related to its orthodontic and implant solutions segments.

Restructuring and Growth Plan

The company’s board of directors approved a restructuring plan designed to improve operational performance. Dentsply Sirona expects to incur non-recurring charges between $55 million and $65 million, with the plan anticipated to result in approximately $120 million in annualized cost savings.

A portion of the savings is slated for reinvestment in the company’s “Return-to-Growth” initiatives, including innovation, clinical education, and sales team education.

“Our restructuring program announced today will allow us to streamline operations, improve efficiency and support a more competitive cost structure, while our decision to eliminate the dividend will enable the redeployment of capital toward share repurchases and debt reduction,” says Dan Scavilla, president and chief executive officer, in a release.

Orthodontic Segment Impairment

In the fourth quarter of 2025, Dentsply Sirona recorded non-cash impairment charges for goodwill and other intangible assets of $144 million, net of tax. The charges were related to the orthodontic and implant solutions and connected technology solutions segments.

According to the company, these impairments were driven by lower-than-expected volumes of equipment, implant, and prosthetic products, as well as lowered near-term forecasts, particularly in the US.

New Capital Strategy and 2026 Outlook

Dentsply Sirona has eliminated its quarterly cash dividend to redeploy capital toward debt retirement and share repurchases.

For the full year 2026, the company expects net sales to be in the range of $3.5 billion to $3.6 billion. Adjusted earnings per share is expected to be in the range of $1.40 to $1.50.

Photo: ID 94247149 © Komgrit Pradissagul | Dreamstime.com